These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 3345726)

  • 1. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
    Nardulli AM; Katzenellenbogen BS
    Endocrinology; 1988 Apr; 122(4):1532-40. PubMed ID: 3345726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation. Evidence for a non-hormone binding receptor precursor.
    Mullick A; Katzenellenbogen BS
    J Biol Chem; 1986 Oct; 261(28):13236-46. PubMed ID: 3759961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
    Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation.
    Nardulli AM; Greene GL; O'Malley BW; Katzenellenbogen BS
    Endocrinology; 1988 Mar; 122(3):935-44. PubMed ID: 3342760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D.
    Wei LL; Miner R
    Cancer Res; 1994 Jan; 54(2):340-3. PubMed ID: 8275464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human progesterone receptor transformation and nuclear down-regulation are independent of phosphorylation.
    Sheridan PL; Krett NL; Gordon JA; Horwitz KB
    Mol Endocrinol; 1988 Dec; 2(12):1329-42. PubMed ID: 3063956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-insensitive progesterone receptors in a human breast cancer cell line: characterization of receptors and of a ligand exchange assay.
    Mockus MB; Lessey BA; Bower MA; Horwitz KB
    Endocrinology; 1982 May; 110(5):1564-71. PubMed ID: 7200421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.
    Sarup JC; Rao KV; Fox CF
    Cancer Res; 1988 Sep; 48(18):5071-8. PubMed ID: 3044580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells.
    Wei LL; Krett NL; Francis MD; Gordon DF; Wood WM; O'Malley BW; Horwitz KB
    Mol Endocrinol; 1988 Jan; 2(1):62-72. PubMed ID: 3398843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing.
    Wei LL; Sheridan PL; Krett NL; Francis MD; Toft DO; Edwards DP; Horwitz KB
    Biochemistry; 1987 Sep; 26(19):6262-72. PubMed ID: 3689774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
    Vignon F; Bardon S; Chalbos D; Rochefort H
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors.
    Beck CA; Weigel NL; Edwards DP
    Mol Endocrinol; 1992 Apr; 6(4):607-20. PubMed ID: 1316549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB
    Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
    Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
    Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
    Read LD; Snider CE; Miller JS; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1988 Mar; 2(3):263-71. PubMed ID: 3398853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone-dependent covalent modification and processing of human progesterone receptors in the nucleus.
    Horwitz KB; Francis MD; Wei LL
    DNA; 1985 Dec; 4(6):451-60. PubMed ID: 4092571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels.
    Ree AH; Landmark BF; Eskild W; Levy FO; Lahooti H; Jahnsen T; Aakvaag A; Hansson V
    Endocrinology; 1989 May; 124(5):2577-83. PubMed ID: 2651098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D.
    Clarke CL; Graham J; Roman SD; Sutherland RL
    J Biol Chem; 1991 Oct; 266(28):18969-75. PubMed ID: 1918012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
    Hurd C; Nag K; Khattree N; Alban P; Dinda S; Moudgil VK
    Mol Cell Biochem; 1999 Sep; 199(1-2):49-56. PubMed ID: 10544951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.